Skip to content
PatentBrief
Get alertsTop ↑

How an Implanted Sensor Checks Its Own Accuracy Over Time

This patent describes a method for an electronic device to continuously monitor and evaluate how well an implanted medical sensor, like a glucose sensor, is working by tracking changes in its accuracy over time.

Granted 2018ActiveExpires 2033Owned by DexcomInvented by Ying Li, Mark C. Brister, Apurv Ullas Kamath + 1 more

Original patent title: “Analyte sensor”

Plain-English explanation by SahiLast reviewed · November 8, 2026

This patent describes a method for an electronic device to continuously monitor and evaluate how well an implanted medical sensor, like a glucose sensor, is working by tracking changes in its accuracy over time. Granted to Dexcom in 2018 with 15 claims and 15 forward citations, and it is expected to expire in 2033.

Coverage

What does this patent actually cover?

The patent describes a method for an electronic device to check if an implanted sensor, such as one measuring glucose, is still accurate. It works by first "receiving sensor data from an analyte sensor implanted in a host" (ClaimclaimA numbered sentence at the end of a patent that legally defines what the inventor owns. The most important section.Read more → 1). Next, the device "intermittently calculat[es] a sensitivity of the analyte sensor" (Claim 1). Sensitivity here refers to how effectively the sensor converts the measured substance into a signal. Finally, the device "evaluat[es], using an electronic device, a change in sensitivity by evaluating a plurality of time-spaced sensitivity calculations over a predetermined time period" (Claim 1). This evaluation uses "a priori sensitivity information" to create an "expected sensitivity profile that is a function of time" (Claim 1). For example, if a glucose sensor's accuracy typically drops after 5 days, the system uses this known pattern to better interpret current sensitivity changes.

The gap

What does this patent NOT cover?

  • Does not cover systems that only measure analyte values without also evaluating changes in the sensor's sensitivity.
  • Does not cover sensors that are not implanted in a host's body.
  • Does not cover methods that do not use "a priori sensitivity information" to generate an "expected sensitivity profile."
  • Does not cover systems that only calculate sensitivity once, rather than "intermittently" and evaluating "a plurality of time-spaced sensitivity calculations."
  • Does not cover systems that do not use an electronic device to perform the sensitivity evaluation.

These exclusions are unique to PatentBrief — derived from the actual claim language, not patent-office boilerplate.

Key facts

Patent numberUS 10052055
StatusActive
FieldBiotech & Medicine
AssigneeDexcom
InventorsYing Li, Mark C. Brister, Apurv Ullas Kamath and 1 other
Filed2013
Granted2018
Expires2033
Claims15
Times cited15
LitigationNone on record
Value · $92K–$296KModest

What made this novel

The clever part is using "a priori sensitivity information" – basically, knowing how a sensor's accuracy typically changes over its lifespan – to create an "expected sensitivity profile." This allows the system to not just detect a change in sensitivity, but to evaluate it against a known pattern, making the accuracy assessment more intelligent and predictive.

The Patent Drawing

Representative patent drawing for Analyte sensor (US 10052055)
Representative figure · US 10052055All figures on Google Patents →
Analyte sensor(Primary claim)biotechconsumer electronicssoftwaremedical devicestelecommunications

Schematic visualization of the patent's claim structure. Hand-drawn diagrams in progress for each landmark patent.

Where you've seen this

Real-world examples

01

Dexcom G6 Continuous Glucose Monitoring System

02

Dexcom G7 Continuous Glucose Monitoring System

03

Other continuous glucose monitoring (CGM) devices that adjust for sensor drift

Why it matters

The bigger picture

For people managing conditions like diabetes, the accuracy of continuous glucose monitors (CGMs) is crucial. This patent addresses a key challenge: how sensor accuracy can change over time once implanted. By continuously evaluating and potentially correcting for these changes, it helps ensure that patients and their doctors receive reliable data, leading to better health decisions and improved safety.

Filed

November 5, 2013

Granted

August 21, 2018

Market context

Who's building on this

Companies in this space

Dexcom, the original assigneeassigneeThe entity that owns the patent — usually the inventor's employer or a company.Read more →, continues to be a leader in continuous glucose monitoring (CGM) technology, constantly improving sensor accuracy and longevity. Other major players like Abbott (with its FreeStyle Libre systems) and Medtronic also develop and refine similar technologies to ensure the reliability of their implanted sensors for diabetes management.

Market impact

This patent contributed to the ongoing improvement of continuous glucose monitoring (CGM) device reliability and accuracy. By providing a method to account for sensor drift, it helped build user trust and enabled CGMs to become a more widely adopted tool for diabetes management. This increased reliability helped expand the market for long-term implanted sensors.

Claim 1 — Plain English

What this patent covers

The patent describes a method for an electronic device to check if an implanted sensor, such as one measuring glucose, is still accurate. It works by first "receiving sensor data from an analyte sensor implanted in a host" (Claim 1). Next, the device "intermittently calculat[es] a sensitivity of the analyte sensor" (Claim 1). Sensitivity here refers to how effectively the sensor converts the measured substance into a signal. Finally, the device "evaluat[es], using an electronic device, a change in sensitivity by evaluating a plurality of time-spaced sensitivity calculations over a predetermined time period" (Claim 1). This evaluation uses "a priori sensitivity information" to create an "expected sensitivity profile that is a function of time" (Claim 1). For example, if a glucose sensor's accuracy typically drops after 5 days, the system uses this known pattern to better interpret current sensitivity changes.

The clever bit

The clever part is using "a priori sensitivity information" – basically, knowing how a sensor's accuracy typically changes over its lifespan – to create an "expected sensitivity profile." This allows the system to not just detect a change in sensitivity, but to evaluate it against a known pattern, making the accuracy assessment more intelligent and predictive.

What it does not cover

  • Does not cover systems that only measure analyte values without also evaluating changes in the sensor's sensitivity.
  • Does not cover sensors that are not implanted in a host's body.
  • Does not cover methods that do not use "a priori sensitivity information" to generate an "expected sensitivity profile."
  • Does not cover systems that only calculate sensitivity once, rather than "intermittently" and evaluating "a plurality of time-spaced sensitivity calculations."
  • Does not cover systems that do not use an electronic device to perform the sensitivity evaluation.

Patent timeline

Filing

Application submitted to the patent office

Publication

Application published, typically 18 months after filing

Grant

Patent officially issued

Expiration

Patent enters public domain

PatentBrief Score

Impact Score

Moderate

Citation count

24/40

Moderately cited

Claim breadth

10/20

Broad claimsclaimsThe numbered statements at the end of a patent that legally define what the inventor owns.Read more →

Recency

10/20

Granted 5–10 years ago

Assignee scale

0/20

Independent or smaller assigneeassigneeThe entity that owns the patent — usually the inventor's employer or a company.Read more →

PatentBrief Impact Score — based on citation count, claim breadth, recency, and assignee scale. Not a legal assessment.

Heuristic Value Estimate

What this patent might be worth

Modest

$92K – $296K

Midpoint $185K · 7.0 yr remaining · industry ×2.2

Adjust inputs →

Heuristic only — blends forward/backward citation counts, claim scope, time remaining, litigation history, and CPC-derived industry baseline. Real valuations need a professional appraisal.

Claim text not yet imported for this patent

The original legal language

Original claims

15 claims as filed with the patent office.

Concepts involved

ClaimPrior artNon-obviousnessNoveltySpecificationAssigneePatent term

Citations

Patent lineage

Cites earlier patents

679

earlier patents this invention cites as foundations

View prior art →

Cited by later patents

15

later patents that build on this invention

View patents →

Cite this patent

Li, Y., Brister, M. C., Kamath, A. U., & Yang, R. C. (2018). How an Implanted Sensor Checks Its Own Accuracy Over Time (U.S. Patent No. 10,052,055). U.S. Patent and Trademark Office. https://patentbrief.org/patent/us/10052055/analyte-sensor-10052055

Auto-generated from the patent record. Double-check author order and the issue date against the official USPTO document before submitting.

Embed

Add this patent to your site

Drop this plain-English patent card into any blog post or article — free, no signup. It always links back to the full breakdown here.

<div data-patentlens-widget data-patent-number="US10052055"></div>
<script src="https://patentbrief.org/embed.js" async></script>

Stay in the loop

Get a weekly digest of new patents.

One email per week. No spam. Unsubscribe anytime.

Keep exploring

Related patents you should know

US 4683195 · 1987

How to Make Billions of Copies of a DNA Segment

This patent describes the Polymerase Chain Reaction (PCR), a method to rapidly create many copies of a specific piece of DNA or RNA, enabling its detection and analysis.

Cetus Corp

US 8697359 · 2014

How to Edit Genes in Human Cells Using an Engineered CRISPR System

This patent describes an engineered CRISPR-Cas9 system for precisely cutting DNA in eukaryotic cells to change how genes work, opening the door for gene editing in complex organisms.

Massachusetts Institute of Technology

US 7657849 · 2010

How the iPhone's Slide-to-Unlock Gesture Works

Apple's 2010 patent describes unlocking a device by dragging a specific graphical image across the touchscreen along a predefined path, a gesture that became iconic with the original iPhone.

Apple Inc

US 4733665 · 1988

How Doctors Implant a Permanent Stent Using a Balloon

This patent describes the method for placing a permanent, expandable wire mesh tube inside a blood vessel or other body tube using a balloon-tipped catheter to widen it and keep it open.

Expandable Grafts Partnership

US 4965188 · 1990

How to Make Many Copies of a DNA Piece with Heat

This patent describes the Polymerase Chain Reaction (PCR) method, a technique to make millions of copies of a specific DNA segment using a heat-resistant enzyme and repeated temperature changes.

Cetus Corp

US 4235871 · 1980

How to Encapsulate Active Materials in Lipid Bubbles Efficiently

This patent describes a method for trapping biologically active substances inside tiny, multi-layered fat bubbles called liposomes, using a specific water-in-oil emulsion and gel-forming process to improve how much material gets captured.

Individual

Semantically similar

You might also find these interesting

SEARCH ALL

More to explore

More in Biotech & Medicine

Browse all Biotech & Medicine

New to patents?

What is a patent?How to read a patentAnatomy of a claimHow strong is this patent?What the citations meanWhat it doesn't coverBiotech PatentsPatent glossary
Explore the landscape:biotech patents →consumer electronics patents →software patents →

Common Questions

Frequently Asked Questions

What does How an Implanted Sensor Checks Its Own Accuracy Over Time cover?

This patent describes a method for an electronic device to continuously monitor and evaluate how well an implanted medical sensor, like a glucose sensor, is working by tracking changes in its accuracy over time.

Who owns patent US 10052055?

Dexcom owns this patent, granted in 2018.

When does this patent expire?

This patent is expected to expire on November 5, 2033, when the invention enters the public domain.

What is patent US 10052055 cited by?

This patent has been cited by 15 later patents that build on its ideas.

What problem does this patent solve?

For people managing conditions like diabetes, the accuracy of continuous glucose monitors (CGMs) is crucial. This patent addresses a key challenge: how sensor accuracy can change over time once implanted. By continuously evaluating and potentially correcting for these changes, it helps ensure that patients and their doctors receive reliable data, leading to better health decisions and improved safety.

What does this patent NOT cover?

Does not cover systems that only measure analyte values without also evaluating changes in the sensor's sensitivity.

Same assignee

More from Dexcom

View all →
US 11432772·2022

Smartly Fixing Noisy Glucose Sensor Readings

US 11382539·2022

A Catheter That Measures Glucose While Delivering Medication

US 9282925·2016

How Glucose Sensors Check Their Own Reliability for Insulin Pumps

Patent monitoring

Get notified when Dexcom files a new patent

Get notified when this company files a new patent. Weekly digest · Confirm via email · Unsubscribe anytime.

Last reviewed: November 8, 2026 · PatentBrief is not a law firm and this is not legal advice.